Table 2.
Characteristics of patients transplanted after IVIg.
| Patient | Age (yrs) |
cPRA pre |
cPRA post |
Time to Transplant (months) |
Pre- treatment DSA (MFI) |
Post- treatment DSA (MFI) |
Pre- Transplant |
|---|---|---|---|---|---|---|---|
| 1 | 17 | 47% | 64% | 4 | B57 2250 | A1 1406; A23 1107; B72 2345 |
No DSA |
| 2 | 13 | 59% | 37% | 3 | A11 6369/ 2392; DR13 1199; DQ9 7424; DQ6 9052/ 3900 |
A11 3259; DR13 1128 DQ9 8517, 1326; DQ6 4027, 2009 |
Same as post treatment |
| 8 | 64 | 51% | 24% | 1 | B7 1006; DR52 3792 |
DR52 2020; DQ7 2050/1950/ 1910/ 115 |
Same as post treatment |
| 13 | 35 | 73% | 61% | <1 | A74 7926 | A74 2950 | A74 3441; Cw4 2457; Cw 5 1708 |
| 14 | 43 | 90% | 81% | 1 | DR15 4025; DQ6 19917 |
DR15 3840; DQ6 17225 |
DQ6 16441 |